NIAAA-SUPPORTED RESEARCH OVERVIEW M. Katherine Jung, Ph.D. NIAAA Mississippi State University February 24, 2016 NIAAA areas of interest DMHE Scientific Programs (1) • Alcoholic liver disease occurs in a subset of chronic drinkers, with the progression: steatosis, steatohepatitis, fibrosis, cirrhosis, hepatocellular carcinoma; and in some cases acute hepatitis • Alcohol adversely affects the function, homeostasis and integrity of other organs, including: the lung, the gut, pancreas, cardiovascular system, kidney, bone, and muscle • Alcohol consumption interferes with immune function, resulting in: increased rates of infection, unchecked inflammation leading to tissue damage, impaired healing, enhanced viral hepatitis, and HIV progression • Maternal alcohol consumption during pregnancy can lead to Fetal Alcohol Spectrum Disorders NIAAA areas of interest DMHE Scientific Programs (2) • Alcohol intake is associated with specific cancers, including: head and neck, liver, colon, and breast cancers • Molecular and cellular processes altered or impaired by alcohol metabolism that may underlie the clinically observed health effects include: organelle stress in mitochondria, endoplasmic reticulum, and proteasomes; oxidative imbalances; epigenetic modifications, inflammation and other metabolic disruptions • Biomarkers are needed for early diagnosis of alcohol consumption and alcohol-induced organ damage Director: Dr. Gary Murray (Acting) NIAAA areas of interest Division of Epidemiology and Prevention Research …. seeks to reduce alcohol-related mortality and morbidity and other alcohol-related problems and consequences through the integration and application of epidemiology and prevention science. Director: Dr. Ralph Hingson NIAAA areas of interest Division of Neuroscience and Behavior …promotes research on ways in which neuronal and behavioral systems are influenced by genetic, developmental, and environmental factors in conjunction with alcohol exposure to engender alcohol abuse and alcoholism. Director: Dr. Antonio Noronha NIAAA areas of interest Division of Treatment and Recovery Research …. supports research to better understand the natural history of excessive drinking and alcohol use disorders and factors associated with positive change. Director: Dr. Robert Huebner (Acting) NIAAA areas of interest Division of Medications Development …focuses on pharmacological treatment for alcohol use disorder (AUD) and supports clinical research programs. Director: Dr. Raye Litten (Acting) Grant Mechanisms R01 R21 R03 Research Research Project Grant Exploratory/Developmental Research Grant Small Grant Training F31 F30 F32 T32 Individual Predoc Individual MD/PhD Predoc Individual Postdoc Institutional Training Grant Career Development K99/R00 NIH Pathway to Independence Award K01 Mentored Research K02 Independent Scientist K08 Mentored Clinical Scientist Research K23 Mentored Patient-Oriented Research K24 Midcareer Investigator Award in Patient-Oriented Research Research grants R01 Research Project Grant • Single project • New and established investigators R21 Exploratory/Developmental Research Grant • High risk/high yield • Limited time and $$ • No pilot data necessary R03 Small Grant • Pilot project • Limited time and $$ For everyone Contact your program officer Before you start to write a grant application • To see if the topic area is of interest to, is a priority for, NIAAA (Funding is limited.) • For advice on choice of mechanism (R21 vs R01, which F grant or K grant) While preparing the application • With questions that arise along the way For everyone Contact your program officer After you have received funding • With any questions that arise Only exception: • After application submission and until review has been completed, your point of contact is the Scientific Review Officer (SRO). Getting started The “mechanics” of applying • Register early at grants.gov and eCommons • Can take 8 weeks • SF-424 –Form and Instructions for your mechanism • Page limits, specific requirements Your university submits the grant to NIH, so work with your grants office ahead of time. Getting started The “mechanics” of applying • Read Instructions carefully • Who will be responsible for completing the different forms within the application? • When must your grants office receive the forms in order to submit on time? • Submit well before the deadline, in case of glitches Getting started Strategies for a competitive application State rationale clearly Be organized, lucid, succinct Never assume reviewers will know what you mean Present a thorough and accurate literature review Propose work that can be realistically completed within the project’s time-frame Perform power analysis Publish regularly in high quality journals Recruit expert collaborators to the project when needed (and obtain letters from collaborators) Getting started Strategies for a competitive application Ask others to review your application ahead of timethe more people the betterWho: Colleagues in your lab, in your department, outside your department, those in a different field. Listen to the advice and be willing to make necessary changes. Review and Award Cycles Cycle 1 Receipt date ScienJfic Merit Review Advisory Council Round Earliest Project Start Date Cycle 2 Cycle 3 February-‐March June-‐ July October-‐November June -‐ July October -‐ November February -‐ March October January May December April July Career development Career Development Awards K99/R00 NIH Pathway to Independence Award K01 Mentored Research Scientist K02 Independent Scientist K08 Mentored Clinical Scientist Research K23 Mentored Patient-Oriented Research K24 Midcareer Investigator Award in PatientOriented Research Career development K99/R00 NIH Pathway to Independence Award Eligibility < 4 years post-doc research Duration 1-2 years mentored post-doc; 3 years independent support K99 Salary up to $90,000 DC Research $$ up to $50,000 DC Research $$ up to $249,000 TC R00 Training Support National Research Service Awards (NRSA) Pre-‐doctoral • InsJtuJonal • T32 • Individual • F30 • F31 Max 5 years of aggregate NRSA support, any combinaJon of T32 and individual grant. Post-‐doctoral • InsJtuJonal • T32 • Individual • F32 Max 3 years of aggregate NRSA support, any combinaJon of T32 and individual grant. Training Support Fellowship review criteria • • • • • Applicant Sponsor Research training plan Training potenJal InsJtuJonal and Training environment Also • Human subjects/vertebrate animals • Training in the responsible conduct of research Training Support Fellowship review criteria Important factors: Commitment of the trainee to alcohol research Mentor’s success in the alcohol field and in mentoring trainees Updates Changes in Biosketch Contents NOT-OD-15-085 Length up to 5 pages!!! A. Personal Statement: aspects training; previous work & technical experAse; collaborators or scienAfic environment; past performance. B. PosiJons and Honors C. ContribuJons to Science Briefly describe up to five of your most significant contribuAons to science. Up to 4 relevant peer-‐reviewed publicaAons for each contribuAon. D. Research Support What does it mean to be compliant with the new biosketch policy? CompleAng each secAon (A -‐ Personal Statement; B – PosiAons and Honors; C – ContribuAons to Science; D – Research Support or ScholasAc Performance) Including no more than 5 contribuAons to science with no more than 4 citaAons per contribuAon Ensuring that if you include the opAonal link to a full list of your published work in a site like My Bibliography that the URL is public, that it meet all requirements in the instrucAons. ♣ What does it mean to be compliant with the new biosketch policy? (2) Refraining from including informaAon, such as preliminary data, that belongs elsewhere in the applicaAon Following NIH guidance on font type, font size, paper size, and margins (See secAon 2.6 of applicaAon guide) Using PDF format for your biosketch a[achment LimiAng the length of your biosketch to 5 pages or less Update No limit on resubmission NOT-OD-14-074 … “following an unsuccessful resubmission (A1) application, applicants may submit the same idea as a new (A0) application for the next appropriate due date.” SBIR/STTR SBIR Small Business InnovaAon Research STTR Small Business Technology Transfer SBIR/STTR SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM Set-‐aside program for small business concerns to engage in Federal R&D -‐-‐ with potenJal for commercializaJon. SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM Set-‐aside program to facilitate cooperaJve R&D between small business concerns and U.S. research insJtuJons -‐-‐ with potenJal for commercializaJon. NIH SBIR/STTR SBIR/STTR 3-‐Phase Program PHASE I Feasibility Study § Budget Guide: $150K (SBIR); $150K (STTR) Total Costs $225K § Project Period: 6 months (SBIR); 1 year (STTR) Flexible PHASE II Full Research/R&D § $1M (STTR), $1M (SBIR) over two years $1.5M, years flexible PHASE IIB CompeAng Renewal/R&D § Clinical R&D; Complex InstrumentaAon/Tools to FDA § Many, but not all, ICs parAcipate NIAAA parJcipates § Varies ~$1M/year; 3 years To be determined case by case PHASE III CommercializaAon Stage § NIH, generally, not the “customer” § Consider partnering and exit strategy early SBIR/STTR SBIR STTR I [R41] 1 1 [R43] Phase I Phase 2 [R44] Phase II Phase II [R42] 2 FastTrack FastTrack Type 1 R44 Type 1 R42 NIH SBIR/STTR Budget Allocations FY2015 NIMHD NIAAA NIDCR NIAMS NHGRI NIDCD NINR ORIP NIBIB 2.9% SBIR $690M 0.40% STTR $95M Total FY2015 $786M NCCAM NLM NCI NIEHS NCATS NEI NIDA NIAID NIA NICHD NIMH NHLBI NINDS NIDDK NIGMS Small businesses must be up-‐to-‐date on FIVE registraJons 1) SAM = System for Award Management (formerly CCR) MUST BE RENEWED ANNUALLY 2) DUNS 3) Grants.gov 4) eRA Commons 5) Small Business AdministraJon (SBA) Company Registry If the SBC moves, changes their address, or changes their name, they will have to go into all of the systems and update their informaJon. New hfp//sbir.nih.gov 32 SBIR/STTR New SBIR/STTR Standard Due Dates * EffecJve September 5, 2015 Cycle I Due Date Cycle II Due Date Cycle III Due Date September 5 January 5 April 5 Thank you For more information, please contact: Kathy Jung -- [email protected] Oh, and… Talk to your program officer! STTR: Small Business Technology Transfer SBIR: Small Business Innovation Research • Set-aside program to fund small business early stage R&D • For small business concerns (SBC) that are organized as for-profit USbased businesses with fewer than 500 employees • SBC must do at least 2/3 of R&D work in Phase I, at least 1/2 in Phase II • PI must be greater than 50% employed by SBC • Proof-‐of-‐Concept study • $150,000 over 6 mo (SBIR), 1 year (STTR); max $225,000* NEW Direct-toPhase II Phase I FEASIBILITY • Basic SBC eligibility same as SBIR • Formal cooperative R&D effort with a US research institution • SBC must do minimum 40% of work; research institution must do minimum 30% of work • PI may be primarily employed by either SBC or research institution • Technology valida-on & clinical transla-on • Follow-‐on funding for SBIR Phase II awardees • Expecta-on that applicants will secure substan-al 3rd-‐party investor funds • $1M per year over 3 years-‐ varies Phase II DEVELOPMENT Fast-Track Application Combined Phase I & II NCI SBIR Phase IIB Bridge Award Phase III COMMERCIALIZATION CROSSING THE VALLEY OF DEATH • Commercializa-on stage • Use of non-‐SBIR/STTR funds • Research & Development • Commercializa-on plan required • $1M over 2 years; max $1.5M* Benefits of the SBIR/STTR Programs • Funding is non-dilutive & doesn’t impact company stock • Awards are not loans; no repayment is required • Intellectual property rights are retained by the small business • Awards provide company recognition, verification, and visibility • Projects are vetted through NIH’s rigorous scientific peer review • Can be used as leverage to attract additional funding FY16 SBIR/STTR Funding ~$877M at NIH ~$13M at NIAAA SBIR/STTR Program Goals • Stimulate technological innovation • Meet Federal R&D needs • Foster & encourage participation in innovation & entrepreneurship by socially & economically disadvantaged persons • Increase private-sector commercialization of innovations derived from Federal R&D funding Small Business Innovation Research & Small Business Technology Transfer Programs SBIR - STTR: Advancing Medicine Through Innovation The NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs award federal research grants to small businesses conducting biomedical research. The purpose of these programs is to spur technological innovation and help the federal government meet its research and development (R&D) needs, with the ultimate goal being commercialization of these innovative technologies and improved public health. FAST TRACK Phase I Register your business Choose program & submit application Phase III Phase II Niche CAP NIH’s SBIR and STTR Programs Can Help Your Small Business Receive R&D Funding Follow these steps to find out how to get started on your application: Determine which Funding Opportunity is Best Suited for You Funding Opportunity Announcements (FOAs): SBIR (PA-14-071) and STTR (PA-14-072) NIH is interested in YOUR research ideas - apply using the Omnibus solicitation FOAs: Issued by NIH’s Institutes and Centers (ICs) Decide between SBIR and STTR Funding SBIR: Principal Investigator: Must be employed by the small business Research Partner: Research partner optional, total effort up to 33% for Phase I and 50% for Phase II STTR: Principal Investigator: Can be employed by the small business or a non-profit research institution Research Partner: Required. Formal collaborative effort between small business (minimum 40%) and research institution (minimum 30%) Submit Your Application Early The grants registration process can take 6-8 weeks! There are 5 required registrations: 1. DUNS 2. Sam.gov 3. Grants.gov 4. eRA Commons 5. SBA Registry Standard Grant Due Dates: Phase I and Phase II: April 5, August 5, December 5 AIDS and AIDS-related: May 7, September 7, January 7 If you have questions about any of these steps, please contact [email protected], or the program officer at the NIH IC that’s most clearly related to your research topic. Contact information is located in the SBIR/STTR Omnibus solicitations. Stay Connected! Subscribe to the SBIR/STTR listserv: Email [email protected] with this text in the message body: “subscribe SBIR-STTR your name” Contact Us: [email protected] Website: sbir.nih.gov Follow us on Twitter: @NIHsbir Follow the below steps to get started on the application process! Confirm your small business concern (SBC) meets eligibility requirements SBIR Omnibus (PA-14-071) STTR Omnibus (PA-14-072) CONTACT NIH BEFORE APPLYING Develop an innovative research idea for your SBC Five required registrations: 1. DUNS 4. eRA Commons 2. SAM.gov 5. SBA Registry 3. Grants.gov CHOOSE ONE FOA Targeted SBIR/STTR FOAs $ Awardee conducts research Funding decisions and awards are made NIH Center for Scientific Review evaluates your grant on scientific merit and commercialization potential Submit your SBIR/STTR grant application to NIH electronically APPLICATION PROCESS 6 - 9 MONTHS Feasibility study for 6 months - $150K SBIR, $150K STTR Full R&D for 2 years - $1M SBIR, $1M STTR SUBMIT FOR PHASE IIB IF APPLICABLE Phase IIB CAP Fast Track: SUBMIT FOR PHASE II Phase II Niche For active Phase I Awardees One application for Phase I and Phase II that is submitted and reviewed together. Phase I For Phase II or IIB Awardees $1M per year for up to 3 years - Must have initial Phase II to apply. Some NIH ICs offer Phase IIB awards for projects that require extraordinary time and effort in the R&D phase. OBTAIN OUTSIDE FUNDING SOURCES Phase III Commercialization - Non-SBIR/STTR funds NIH Technology Assistance Programs: Helping You Bridge the Gap Niche Assessment Program: Provides active Phase I awardees with market research, consumer and competition analysis. Commercialization Assistance Program (CAP): Trains Phase II awardees on developing tailored market entry strategies, building strategic alliances and partnerships, and developing FDA regulatory and reimbursement paths, as well as financing strategies and expertise on intellectual property matters. Visit sbir.nih.gov for more information! IC Program Contacts | NIH SBIR/STTR Page 1 of 2 HHS SBIR/STTR Agency Contact Information Questions of a general nature about the HHS SBIR/STTR Program may be directed to the following: SBIR/STTR Program Office Fax: 301-480-0146 [email protected] Dr. Matthew Portnoy Mr. J.P. Kim Phone: 301-435-2688 Phone: 301-435-0189 [email protected] [email protected] Awarding Component Mr. Robert Vinson Phone: 301-435-2713 [email protected] Scientific/Research Contact Ms. Betty Royster Phone: 301-402-1632 [email protected] Ms. Julie Beaver Phone: 301-496-8807 [email protected] Financial/Grants Mgmt Contact National Institute on Aging http://www.nia.nih.gov Dr. Michael-David A.R.R. Kerns Phone: 301-402-7713 Fax: 301-402-2945 Email: [email protected] Ms. Linda Whipp Phone: 301-496-1472 Fax: 301-402-3672 Email: [email protected] National Institute on Alcohol Abuse and Alcoholism http://www.niaaa.nih.gov Dr. Kathy Jung Phone: 301-443-8744 Fax: 301-594-0673 Email: [email protected] Ms. Judy Fox Phone: 301-443-4704 Fax: 301-443-3891 Email: [email protected] National Institute of Allergy and Infectious Diseases http://www.niaid.nih.gov Dr. Natalia Kruchinin Phone: 240-669-2919 Fax: 240-627-3162 Email: [email protected] Ms. Vandhana Khurana, MBA Phone: 240-669-2966 Fax: 301-493-0597 Email: [email protected] Jason Lundgren Phone: 240-669-2973 Fax: 301-493-0597 Email: [email protected] National Institute of Arthritis and Musculoskeletal and Skin Diseases http://www.niams.nih.gov/ Dr. Xibin Wang Phone: 301-451-3884 Fax: 301-480-1284 Email: [email protected] Ms. Aleisha S. James Phone: 301-594-3968 Fax: 301-480-5450 Email: [email protected] National Institute of Biomedical Imaging and Bioengineering http://www.nibib.nih.gov/ Mr. Todd Merchak Phone: 301-496-8592 Fax: 301-480-1614 Email: [email protected] Mr. James Huff Phone: 301-451-4786 Fax: 301-451-5735 Email: [email protected] National Cancer Institute http://sbir.cancer.gov Mr. Michael Weingarten Dr. Greg Evans Dr. Andrew Kurtz Phone: 240-276-5300 Fax: 240-276-5236 Email: [email protected] Ms. Jacquelyn Boudjeda Phone: 240-276-6312 Fax: 240-276-7913 Email: [email protected] Eunice Kennedy Shriver National Institute of Child Health and Human Development http://www.nichd.nih.gov Louis A. Quatrano, Ph.D. Phone: 301-402-4221 Fax: 301-402-0832 Email: [email protected] Mr. Ted Williams Phone: 301- 326-6450 Fax: 301- 451-5510 Email: [email protected] National Institute on Drug Abuse http://www.nida.nih.gov Elena Koustova, Ph.D., MBA Phone: 301-496-8768 Email: [email protected] Ms. Diana Haikalis, M.B.A. Phone: 301-443-6710 Fax: 301-594-6849 Email: [email protected] National Institute on Deafness and Other Communication Disorders http://www.nidcd.nih.gov Dr. Roger L. Miller Phone: 301-402-3458 Fax: 301-402-6251 Email: [email protected] Mr. Christopher P. Myers Phone: 301-435-0713 Fax: 301-402-1758 Email: [email protected] National Institute of Dental and Craniofacial Research http://www.nidcr.nih.gov Dr. R. Dwayne Lunsford Phone: 301-594-2421 Fax: 301-480-8319 Email: [email protected] Ms. Diana “Dede” Rutberg Phone: 301-594-4798 Fax: 301-480-3562 Email: [email protected] National Institute of Diabetes and Digestive and Kidney Diseases http://www.niddk.nih.gov Ms. Christine Densmore Phone: 301-402-8714 Fax: 301-480-8300 Email: [email protected] Ms. Pamela Love Phone: 301-435-6198 Email: [email protected] National Institute of Environmental Health Sciences http://www.niehs.nih.gov Dr. Daniel T. Shaughnessy Phone: 919-541-2506 Fax: 919-541-4606 Email: [email protected] Ms. Pam Clark Phone: 919-541-7629 Fax: 919-541-2860 Email: [email protected] National Eye Institute http://www.nei.nih.gov Dr. Jerome Wujek Phone: 301-451-2020 Fax: 301-496-2297 Email: [email protected] Mr. William Darby Phone: 301-451-2020 Fax: 301-496-9997 Email: [email protected] National Institute of General Medical Sciences http://www.nigms.nih.gov/ Dr. Scott Somers Phone: 301-594-3827 Fax: 301-480-2802 Email: [email protected] Ms. Patrice Molnar Phone: 301-594-5136 Fax: 301-480-2554 Email: [email protected] National Heart, Lung, and Blood Institute http://www.nhlbi.nih.gov/research/funding/sbir/ Dr. Jennifer Shieh Phone: 301-496-2149 https://sbir.nih.gov/engage/ic-contacts Ms. Ann Marie Brasile Mejac, AA,CRA Phone: 301-435-0164 Fax: 301-451-5462 Email: [email protected] 2/17/2016 IC Program Contacts | NIH SBIR/STTR Page 2 of 2 Fax: 301-480-0422 Email: [email protected], Ms. Leslie West-Bushby Phone: 301-435-1498 Fax: 301-451-5462 Email: [email protected] [email protected] National Human Genome Research Institute http://www.genome.gov Dr. Michael W. Smith Phone: 301-496-7531 Fax: 301-480-2770 Email: [email protected] Ms. Monika Christman Phone: 301-435-7860 Fax: 301-451-5434 Email: [email protected] National Institute of Mental Health http://www.nimh.nih.gov Dr. Margaret C. Grabb Phone: 301-443-3563 Fax: 301-443-1731 Email: [email protected] Ms. Rebecca Claycamp Phone: 301-443-2811 Fax: 301-443-6885 Email: [email protected] National Institute on Minority Health and Health Disparities http://www.nimhd.nih.gov/ Mr. Vincent A. Thomas, Jr. MSW, MPA Phone: 301-402-2516 Fax: 301-480-4049 Email: [email protected] Ms. Priscilla Grant, J.D. Phone: 301-594-8412 Fax: 301-480-4049 Email: [email protected] National Institute of Neurological Disorders and Stroke http://www.ninds.nih.gov Ms. Stephanie Fertig Phone: 301-496-1779 Fax: 301-402-1501 Email: [email protected] Ms. Tijuanna Decoster Phone: 301-496-9231 Fax: 301-402-4370 Email: [email protected] National Institute of Nursing Research http://www.ninr.nih.gov/ Mr. Augusto Diana Phone: 301-402-6423 Fax: 301-480-8260 Email: [email protected] Ms. Judy L. Sint Phone: 301-402-6959 Fax: 301-402-4502 Email: [email protected] National Center for Advancing Translational Sciences http://www.ncats.nih.gov Lili M. Portilla, MPA Phone : 301-217-2589 Fax : 301-480-3661 Email: [email protected] Ms. Artisha Y. Eatmon Phone: 301-435-0845 Fax: 301-480-3777 Email: [email protected] National Center for Complementary and Integrative Health http://nccih.nih.gov Dr. John S. Williamson Phone: 301-496-2583 Fax: 301-480-1552 Email: [email protected] Ms. Shelley Carow Phone: 301-594-3788 Fax: 301-480-1552 Email: [email protected] National Library of Medicine http://www.nlm.nih.gov Dr. Jane Ye Phone: 301-594-4882 Fax: 301-402-2952 Email: [email protected] Mr. Dwight Mowery Phone: 301-496-4221 Fax: 301-402-0421 Email: [email protected] Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs http://dpcpsi.nih.gov/ORIP/index.aspx Dr. Miguel Contreras Phone: 301-594-9410 Fax: 301-480-3819 Email: [email protected] Ms. Artisha Y. Eatmon Phone: 301-435-0845 Fax: 301-480-3777 Email: [email protected] Centers for Disease Control and Prevention (CDC) http://www.cdc.gov Overall CDC Coordinator: Mr. Sean David Griffiths Phone: 404.639.4641 Email: [email protected] Dr. Rachel Kaufmann (CSELS) Phone: 404-639-4641 Fax: 404-639-4903 Email: [email protected] Dr. Virginia Cain (NCHS) Phone: 301-458-4395 Fax: 301-458-4020 Email: [email protected] Dr. Paul Smutz (NCIPC) Phone: 770-488-4850 Fax: 770-488-1665 Email: [email protected] Dr. Steve Dearwent (NIOSH) Phone: 404-498-6382 Fax: 404-498-0751 Email: [email protected] Ms. Devi Hawkins (CSELS, NCIPC) Phone: 770-488-2543 Fax: 770-488-2670 Email: [email protected] Sharron Orum (NCHS) Phone: 770-488-2716 Fax: 770-488-2847 Email: [email protected] Ms. Mary Pat Shanahan (NIOSH) Phone: 412-386-4453 Fax: 412-386-6429 Email: [email protected] Food and Drug Administration (FDA) http://www.fda.gov Ms. Kimberly Pendleton Chew Mr. Bryce Jones Phone: 301-827-9363 Phone: 240-402-2111 Fax: 301-827-0505 Email: [email protected] Email: [email protected] Administration for Children and Families http://www.acf.hhs.gov Naomi Goldstein Phone: 202-401-9220 Fax: 202-205-3598 Email: [email protected] https://sbir.nih.gov/engage/ic-contacts Karl Koerper Phone: 202-401-9220 Fax: 202-205-3598 Email: [email protected] 2/17/2016 Peer Review & Grant Opportunities at NIH Abraham P. Bautista, Ph.D. Director, Office of Extramural Activities Executive Secretary NACAAA NIAAA/NIH/DHHS http://www.niaaa.nih.gov/ National Institutes of Health • NIH’s mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability. • NIH provides leadership and direction to programs designed to improve the health of the Nation by conducting (INTRAMURAL) and supporting (EXTRAMURAL) research National Institutes of Health (OD) (27 Institutes and Centers) http://www.nih.gov/icd/index.html http://www.nih.gov/institutes-nih/directors-nih-institutes-centers NCI* NEI NHLBI NHGRI NIA NIAAA* NIAID NIAMS NIBIB NICHD NIDCD NIDCR NIDDK NIDA* NIEHS NIGMS NIMH NINDS NINR NLM CIT CSR FIC NCCIH NIMHD NCATS CC *Collaborative Research on Addiction at NIH (CRAN) http://addictionresearch.nih.gov/ NIAAA VISION STATEMENT • To support and promote the best science on alcohol and health for the benefit of all by: – Increasing the understanding of normal and abnormal biological functions and behavior relating to alcohol use – Improving the diagnosis, prevention, and treatment of alcohol use disorders – Enhancing quality health care Preparation and Submission of Grant Applications and Cooperative Agreements • Federal Officials – Program Officers/Directors (scientific programs) – Scientific Review Officers (first level of review –grants and cooperative agreements) – Executive Secretaries of Advisory Councils (second level of review) – Grants Management Specialists (grants management of funded grants only) Funding Opportunity Announcements (FOA) • RFA (Request for Applications) Set-asides – RFA AA 11-001 • PA (Program Announcement) No set-asides – PA 06-181 • PAS (PA) with set-asides – PA 11-165 • PAR (PA with receipt, referral, review info) May or may not have set-aside funding – PAR 03-134 N.B. Applications not responding to an RFA are returned without review. Grants Process at a Glance How to read your Grant Number Type Activity IC Number Year 1 R21 AI 012345 01-A1 2 R01 AA 543210 06 3 R01 DA 543210 06-S1 9 R01 MH 543210 09 5 R01 CA 543210 06-S1 PEER REVIEW NIH Tips for Applicants (YouTube Video) – NIH Tips for Applicants: http://www.youtube.com/watch? v=9cNRMsCGfHo&feature=chann el CENTER FOR SCIENTIFIC REVIEW (CSR) http://public.csr.nih.gov/Pages/default.aspx http://cms.csr.nih.gov/ All applications go through the Division of Receipt and Referral CSR. – Submission of e-grant applications, Grants.gov – https://era.nih.gov/files/assist_user_guide.pdf Administrative Supplement applications are submitted through Grants.gov or eRA directly to the institute of the parent grant. (not subjected to peer review). Locus of Review • IC Reviews Vs. CSR Reviews • Standing study section Vs. Special Emphasis Panel (Rosters of all NIH review panels are available at https://public.era.nih.gov/pubroster/ Integrated Review Groups (CSR), Examples • Related Research (AARR) IRG-Study Sections – AIDS Immunology & Pathogenesis (AIP) – NeurAIDS oAIDS and End Organ (NAED) – AIDS Clinical and Epidemiology (ACE) • Risk Prevention Health Behavior (RPHB) IRG-Study Sections – Risk, Prevention and Intervention for Addictions (RPIA) – Psychosocial Development, Risk and Prevention (PDRP) NIAAA REVIEW SUBCOMMITTEES http://www.niaaa.nih.gov/grant-funding/application-process/niaaa-scientific-reviewgroup-rosters • AA-1 Biomedical Sciences (non-Brain) • AA-2 Prevention and Epidemiology • AA-3 Clinical, Treatment and Health Services • AA-4 Neuroscience and Behavior • ZAA-1 (Special Emphasis Panel for grants and contracts) • ZAA-1 (Special Emphasis Panel for Fellowship applications) • ZAA-1 (Special Emphasis Panel for T32/T35 Centers – NIAAA & NIDA) • ZAA1 SRC 99 – is not a study section Review Meetings (Standing IRG, SEP or Editorial Board) • Face to face meeting – Site visits, reverse site visits included. • Internet Assisted Meeting • Video Conference • Teleconference • Mail Review/Editorial Board Review Criteria (R01, R03, U01) • Significance • Investigators • Innovation • Approach • Environment Review Criteria (R24, U24) Resource Mechanisms • Investigators • Approach/Innovation • Environment SCORING Review Criteria (Fellowships) • Candidate • Sponsors/Mentors • Research Training Plan • Training Potential • Institutional Support Non-scorable criterion: Training in “Responsible Conduct of Research” At the Review Meeting • Scientific Review Officer: Responsible for the administrative issues. • Chairperson and Members: Responsible for the scientific issues. At the Review Meeting • Federal Requirement: – Confidentiality – Conflict of Interest – Scientific Misconduct • Review Order – Discussion of the upper half, scored • Streamlining – lower half not discussed, no assigned priority score Percentiling • R01s are percentiled • R01s in RFAs are not percentiled Percentile is the assigned rank of an application based on the scoring pattern of a Study Section (at least 20 applications during the last 3 rounds). E.g. Priority score of 30 may have a percentile of 20%. Priority score of 10 is assigned a percentile of 1% After the review • Summary Statements are released within 30 days after the review, or at least 30 days before the Council Meeting, which ever is earlier • Scores are released within 3 business days • Second Level of Review by the IC’s National Advisory Council • Funding Recommendation to the IC Directors • Grants Management Office for the Issuance of NGA (Notice of Grant Award) • Description/Abstract/Total Cost of funded grants reported in http://www.projectreporter.nih.gov/reporter.cfm for public information Fiscal Year 2015 Funding Update From NIAAA Director’s Report to Council http://www.niaaa.nih.gov/about-niaaa/our-work/advisory-council/directorsreports-council/niaaa-directors-report-institute-11 • NIAAA’s final appropriation for NIAAA was $447.2 million. – NIAAA awarded 668 research project grants (RPGs), including 156 competing awards, which corresponds to a success rate of 18 percent. – NIAAA funded 18 research centers for $28.0 million. – NIAAA funded 135 other research grants for $37.2 million, including career awards, one cooperative clinical agreement, and several resource and conference grant awards. – NIAAA supported 277 full-time training positions for $12.7 million. – NIAAA funding for its research and development contract portfolio was $36.6 million. – NIAAA support for intramural research totaled $49.5 million. FISCAL YEAR 2016 • NIH received $32.3 billion ($ 2 billion above 2015) • NIAAA received $ 467.7 M ($ 20.5 million or 4.9 % over 2015) NIAAA 2015 Success Rate • R01 • R03 • R21 - 15% - 14% - 14% • F30 • F31 • F32 - 71% - 45% - 24% NIH RePORTER Unfunded Applications remain confidential and are not public information RECENT NIH UPDATES Enhancing Reproducibility through Rigor and Transparency ( http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-103.html) One of NIH’s four stated goals is to exemplify and promote the highest level of scientific integrity, public accountability, and social responsibility in the conduct of science (see http://www.nih.gov/about/mission.htm). Enhancing Reproducibility through Rigor and Transparency Review criteria will focus on 1. 2. 3. 4. the scientific premise of the proposed research, rigorous experimental design for robust and unbiased results, consideration of relevant biological variables, authentication of key biological and/or chemical resources. Timeline: Guidelines for reviewers will be available before the review of applications for October 2016 Council Cycle. NIAAA Contact Information Office of the Director (George F. Koob, Ph.D, Director, NIAAA) • Patricia Powell, Ph.D., Acting Deputy Director NIAAA – Kendall Bryant, Ph.D., AIDS/HIV Coordinator – Judy Arroyo, Ph.D., Diversity Coordinator – Margaret Murray, Ph.D., International Liaison Officer Office of Extramural Activities, NIAAA • Abraham P. Bautista, Ph.D., Director (301 443 9737) [email protected] – Judy Fox, Chief, Grants Management Branch – Ranga Srinivas, Ph.D., Chief Extramural Project Review Branch Division Directors, NIAAA • Antonio Noronha, Ph.D. (DNB) • Gary Murray, Ph.D. (DMHE) – M. Katherine Jung, Ph.D. (NIAAA Small Business Liaison Officer) • Ralph Hingson, D. Sc. (DEPR) • Robert Huebner, Ph.D. (DTRR) • Raye Litten, Ph.D. (DMD)
© Copyright 2026 Paperzz